Results 281 to 290 of about 9,643,208 (350)

Genetics of Parkinson´s disease: Recessive forms

Philippe A. Salles, X. Pizarro-Correa, Pedro Chaná‐Cuevas   +2 more
openalex   +1 more source

Sampling Defective Pathways in Parkinson Disease

, 2019
Juan Luis Fernández‐Martínez, Enrique J. deAndrés‐Galiana, Enrique J. deAndrés‐Galiana, Ana Cernea, Francisco Javier Fernández-Ovies, Manuel Menéndez‐González   +5 more
openalex   +1 more source

NADH‐Reductive Stress Induced by Dihydrolipoamide Dehydrogenase Activation Contributes to Cuproptosis

Advanced Science, EarlyView.
This study demonstrates a cuproptosis mechanism involving nicotinamide adenine dinucleotide (NADH)‐reductive stress in neural cells. Copper activates dihydrolipoamide dehydrogenase under mitochondrial pH, accumulating NADH. Copper also induces mitochondrial permeability transition pore opening, facilitating NADH translocation to the cytosol and ...
Si‐Yi Zhang, Xing‐Hua Ren, Cheng‐Hong Zhang, Zhan‐You Wang   +3 more
wiley   +1 more source

Exploring behavior, motivation, and barriers to exercise in Parkinson disease. [PDF]

Clin Park Relat Disord
Haussler AM, Baudendistel ST, Tueth LE, Earhart GM.   +3 more
europepmc   +1 more source

Assessment of the Dysautonomia Presence in Parkinson disease through Cardiovascular Signal Analysis

, 2017
S. Alvarado-Jalomo, N. A. Alvarado Álvarez, G. Dorantes Méndez   +2 more
openalex   +2 more sources

Remote Activation of Spinal TRPV1 by Magnetic Nanocubes Confers Cardioprotection Against Myocardial Ischemia‐Reperfusion Injury

Advanced Science, EarlyView.
Fe‐based magnetic nanocubes conjugated with TRPV1 antibodies (FeNCs‐TRPV1) are developed for the specific targeting of TRPV1 channels. Intraspinally injected FeNCs‐TRPV1 induces TRPV1 desensitization in rats exposed to repetitive and transient ACMF.
Xueying Cheng, Shuangyu Liu, Yu Zhang, Kang Peng, Muge Qile, Chao Wu, Mengyun Dou, Liu Liu, Na Yang, Rui Liu, Guiyang Zhang, Liangping Ni, Gaolin Liang, Fang Yang, Ye Zhang, Shufang He   +15 more
wiley   +1 more source

Long-Term Personalized Adaptive Deep Brain Stimulation in Parkinson Disease: A Nonrandomized Clinical Trial.

JAMA Neurol
Bronte-Stewart HM, Beudel M, Ostrem JL, Little S, Almeida L, Ramirez-Zamora A, Fasano A, Hassell T, Mitchell KT, Moro E, Gostkowski M, Chattree G, de Bie RMA, de Neeling M, Piña-Fuentes D, Swinnen B, Starr PA, Hammer LH, Foote KD, Richardson RM, Flaherty A, Boogers A, Sa'di Q, Meoni S, Castrioto A, Stanslaski S, Summers RLS, Tonder L, Tan Y, Berrier H, Goble TJ, Raike RS, Herrington TM, ADAPT-PD Investigators.   +33 more
europepmc   +1 more source

Low to moderate relationships between gait and postural responses in Parkinson disease [PDF]

, 2017
Duncan, Ryan P, Earhart, Gammon M, McNeely, Marie E, Seidler, Katie J, Sutter, Ellen N   +4 more
core   +1 more source

Antibody‐Empowered Nanomedicine for Precise Biomedical Applications

Advanced Science, EarlyView.
This review explores strategies for functionalizing nanoparticles with antibodies to construct antibody‐empowered nanomedicine. It discusses the classification of these nanomedicines based on antibody structure, with a specific focus on their biomedical applications in diagnostics, bioimaging, and therapeutics for various diseases.
Chen Chen, Xinglin Chen, Zhenhao Gao, Meng Sun, Yaozong Yu, Fang Lv, Qiujun Wang, Jinfeng Zhang   +7 more
wiley   +1 more source